Gradient Investments LLC Novartis Ag Transaction History

Gradient Investments LLC

  • $4.68 Billion
  • Q3 2025

A detailed history of Gradient Investments LLC transactions in Novartis Ag stock. As of the latest transaction made, Gradient Investments LLC holds 10,271 shares of NVS stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,271
Previous 6,419 60.01%
Holding current value
$1.34 Million
Previous $776,000 69.72%
% of portfolio
0.03%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 06, 2025
BUY
$113.5 - $129.73 $437,202 - $499,719
3,852 Added 60.01%
10,271 $1.32 Million
Q2 2025

Jul 08, 2025
BUY
$101.96 - $121.01 $106,344 - $126,213
1,043 Added 19.4%
6,419 $776,000
Q1 2025

Apr 09, 2025
BUY
$97.14 - $115.57 $8,839 - $10,516
91 Added 1.72%
5,376 $599,000
Q4 2024

Jan 21, 2025
BUY
$96.78 - $117.18 $6,871 - $8,319
71 Added 1.36%
5,285 $514,000
Q3 2024

Oct 15, 2024
SELL
$106.13 - $120.89 $10,506 - $11,968
-99 Reduced 1.86%
5,214 $599,000
Q2 2024

Jul 18, 2024
BUY
$92.57 - $107.37 $30,548 - $35,432
330 Added 6.62%
5,313 $565,000
Q1 2024

Apr 23, 2024
SELL
$95.27 - $108.47 $58,305 - $66,383
-612 Reduced 10.94%
4,983 $482,000
Q4 2023

Jan 18, 2024
SELL
$92.27 - $101.54 $12,364 - $13,606
-134 Reduced 2.34%
5,595 $564,000
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $30,787 - $34,167
-325 Reduced 5.37%
5,729 $583,000
Q2 2023

Jul 11, 2023
SELL
$92.52 - $104.91 $19,521 - $22,136
-211 Reduced 3.37%
6,054 $610,000
Q1 2023

Apr 17, 2023
BUY
$80.03 - $92.81 $14,245 - $16,520
178 Added 2.92%
6,265 $576,000
Q4 2022

Jan 10, 2023
SELL
$75.55 - $92.52 $40,645 - $49,775
-538 Reduced 8.12%
6,087 $0
Q3 2022

Oct 14, 2022
SELL
$74.61 - $87.26 $8,580 - $10,034
-115 Reduced 1.71%
6,625 $504,000
Q2 2022

Jul 11, 2022
SELL
$80.52 - $93.75 $7,729 - $9,000
-96 Reduced 1.4%
6,740 $570,000
Q1 2022

May 26, 2022
SELL
$80.11 - $90.62 $26,195 - $29,632
-327 Reduced 4.57%
6,836 $600,000
Q4 2021

Jan 12, 2022
SELL
$79.7 - $88.13 $2,391 - $2,643
-30 Reduced 0.42%
7,163 $627,000
Q3 2021

Oct 18, 2021
BUY
$81.78 - $95.14 $20,445 - $23,785
250 Added 3.6%
7,193 $588,000
Q2 2021

Jul 12, 2021
BUY
$85.24 - $94.15 $7,160 - $7,908
84 Added 1.22%
6,943 $633,000
Q1 2021

Apr 21, 2021
SELL
$83.5 - $98.47 $28,891 - $34,070
-346 Reduced 4.8%
6,859 $586,000
Q4 2020

Jan 08, 2021
SELL
$78.07 - $94.43 $49,652 - $60,057
-636 Reduced 8.11%
7,205 $627,000
Q3 2020

Oct 06, 2020
SELL
$82.14 - $91.0 $11,335 - $12,558
-138 Reduced 1.73%
7,841 $682,000
Q2 2020

Jul 10, 2020
SELL
$80.93 - $91.1 $724,080 - $815,071
-8,947 Reduced 52.86%
7,979 $697,000
Q1 2020

Apr 07, 2020
SELL
$70.67 - $99.01 $61,482 - $86,138
-870 Reduced 4.89%
16,926 $1.4 Million
Q4 2019

Jan 15, 2020
SELL
$84.35 - $95.37 $118,258 - $133,708
-1,402 Reduced 7.3%
17,796 $1.69 Million
Q3 2019

Oct 10, 2019
SELL
$85.54 - $94.26 $213,764 - $235,555
-2,499 Reduced 11.52%
19,198 $1.67 Million
Q2 2019

Jul 16, 2019
BUY
$75.4 - $92.8 $1.62 Million - $1.99 Million
21,497 Added 10748.5%
21,697 $1.98 Million
Q1 2019

Apr 11, 2019
SELL
$75.32 - $86.15 $17,248 - $19,728
-229 Reduced 53.38%
200 $19,000
Q4 2018

Jan 18, 2019
BUY
$73.66 - $82.02 $2,136 - $2,378
29 Added 7.25%
429 $37,000
Q3 2018

Oct 11, 2018
SELL
$66.94 - $77.43 $4,685 - $5,420
-70 Reduced 14.89%
400 $34,000
Q2 2018

Aug 09, 2018
BUY
$64.91 - $73.36 $4,543 - $5,135
70 Added 17.5%
470 $36,000
Q1 2018

Apr 11, 2018
SELL
$70.39 - $84.15 $17,456 - $20,869
-248 Reduced 38.27%
400 $32,000
Q4 2017

Feb 07, 2018
BUY
$72.33 - $77.64 $46,869 - $50,310
648
648 $54,000

Others Institutions Holding NVS

# of Institutions
1,560
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $280B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email